Risk Factors for Atherosclerotic Vascular Diseases with Special Reference to the Relationship between Apolipoprotein E Mutations and Hyperlipidemia
- 1 August 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 598 (1) , 58-65
- https://doi.org/10.1111/j.1749-6632.1990.tb42276.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Reciprocal effects of apolipoprotein E alleles (ε2 AND ε4) on plasma lipid levels in normolipidemic subjectsClinical Genetics, 1986
- Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.Journal of Clinical Investigation, 1984
- A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.Journal of Clinical Investigation, 1984
- A new isoform of apolipoprotein E — Apo E-5 — Associated with hyperlipidemia and atherosclerosisAtherosclerosis, 1984
- Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patientEuropean Journal of Clinical Investigation, 1984
- Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.Journal of Clinical Investigation, 1983
- Lipoprotein receptors and cholesterol homeostasisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983